Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SCVM > SEC Filings for SCVM > Form 8-K on 3-Apr-2014All Recent SEC Filings

Show all filings for SCIVANTA MEDICAL CORP

Form 8-K for SCIVANTA MEDICAL CORP


3-Apr-2014

Unregistered Sale of Equity Securities, Financial Statements and Exhibits


Item 3.02. Unregistered Sales of Equity Securities

On April 1, 2014, Scivanta Medical Corporation (the "Company") issued a 10% convertible debenture to an individual investor (the "Debenture"). The gross proceeds received in connection with this private placement were $75,000. The Debenture has a one year term, with both principal and interest due on April 1, 2015, and bears interest at a rate of 10% per annum.

The entire principal amount of the Debenture and the interest accrued thereon is convertible into shares of the Company's common stock at the option of the holder: (a) upon the Company issuing equity securities and/or debt in a transaction or a series of transactions resulting in aggregate gross proceeds to the Company of a least $3,000,000 (a "Qualified Financing"); (b) at the maturity date of the Debenture; or (c) upon a change in control of the Company, as defined in the Debenture. Upon the occurrence of a Qualified Financing, the Debenture is convertible into shares of the Company's common stock at a conversion price equal to: (i) eighty percent (80%) of the per share price paid by the purchasers of the Company's common stock in the Qualified Financing; (ii) eighty percent (80%) of the per share conversion price of any instrument convertible into shares of the Company's common stock issued in the Qualified Financing, if no shares of the Company's common stock are issued in the Qualified Financing; or (ii) $0.13, if no shares of the Company's common stock or instruments convertible into shares of the Company's common stock are issued in the Qualified Financing. On the maturity date or upon a change in control of the Company, the Debenture is convertible into shares of the Company's common stock at $0.13 per share. The quoted market price of the Company's common stock as of April 1, 2014 was $0.13 per share.

The Debenture holder received a warrant to purchase shares of the Company's common stock equal to twenty percent (20%) of the principal amount of the Debenture divided by: (a) eighty percent (80%) of the per share price paid by the purchasers of Company's common stock in a Qualified Financing; (b) eighty percent (80%) of the per share conversion price of any instrument convertible into shares of the Company's common stock issued in a Qualified Financing, if no shares of Company's common stock are issued in the Qualified Financing; or (c) $0.13, if no shares of the Company's common stock or no instruments convertible into shares of the Company's common stock are issued in a Qualified Financing or if a Qualified Financing is not consummated within one (1) year from the warrant issuance date.

All of the shares of the Company's common stock underlying the warrant vest on the earlier of (i) one (1) year from the warrant issuance date, and (ii) the consummation of a Qualified Financing. The exercise price of the warrant will be subject to adjustment for stock dividends, stock splits, or similar events.

An aggregate amount of 576,923 shares of the Company's common stock can be issued pursuant to the Debenture at the current conversion price of $0.13 per share. The Company will use the proceeds received in this private placement for working capital purposes.


In connection with the issuance of the Debenture, the Company relied on the exemption from registration for a private transaction not involving a public distribution provided by Section 4(2) of the Securities Act of 1933, as amended.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits:

Exhibit
Number    Description

4.1       Form of 10% Convertible Debenture, dated as of April 1, 2014, issued to
          Chris Hynes (incorporated by reference to Exhibit 4.1 to the Company's
          current report on Form 8-K filed with the Securities and Exchange
          Commission on December 17, 2013).


  Add SCVM to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SCVM - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.